Coronary stents market Value Chain Analysis| Key Players: Boston Scientific, Terumo Medical Corporation, Medtronic, Abbott, BIOTRONIK

High demand for minimally invasive surgical procedures will significantly drive coronary stents market growth over the forecast period. Reduction in post-operative trauma and complications with use of minimally invasive surgical procedure is the major growth driver. Reduced hospital stays, and lesser healing time are other advantages associated with use of advanced and miniaturized coronary stents. Aforementioned factors will favor considerable growth in the future.

Favorable government policies such as price control and reimbursement will spur demand for coronary stents in upcoming years. For instance, in 2018, the National Pharmaceutical Pricing Authority (NPPA) of India announced reduction of prices of drug eluting stents. Also, increasing reimbursement for drug eluting stents in Japan will significantly impact market growth. Increasing government initiatives for providing safe and advanced healthcare services will drive business growth during the forecast period.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2966

Drug eluting stent market valued USD 3,286.2 million owing to high adoption rate. Prevention of post operation trauma and other complications such as in-stent restenosis and stent thrombosis will spur the demand for drug eluting stents. Wide array of applications including ST segment elevation myocardial infarction (STEMI), percutaneous coronary intervention and diabetes will foster segmental growth. Various technological advances for improving patient outcomes and development of next generation drug eluting stents will spur demand for drug eluting stents in forthcoming years.

Bioresorbable vascular scaffold (BVS) market will expand at 7.6% CAGR during the forecast timeframe owing to various technological advances and growing burden of coronary artery disease. According to World Health Organization, more than 31% of the world population die from cardiovascular diseases including coronary artery disease. High pervasiveness of coronary artery disease will drive the need for development of advanced and innovative BVS systems for treatment. Shorter recovery time and low post-operative complication are few of the advantages offered by BVS systems. Such factors will favour segmental growth in recent years.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Medtronic
• Abbott
• BIOTRONIK
• Boston Scientific
• Terumo Medical Corporation
• BKK B. Braun Melsungen AG
• Biosensors International Group, Ltd
• Meril Life Sciences India Pvt Ltd
• Microport Scientific Corp
• Elixir Medical Corporation

Coronary stent hospitals business accounted for largest revenue of USD 2,584.7 million in 2017. Segmental growth is due to rising number coronary artery disease cases across the globe. Favourable reimbursement policies in most developed countries for cardiac surgeries. Moreover, government policies for implementation of high-quality patient care will attract large number of patients in hospitals to seek treatments. Growing disease burden and increasing healthcare investments will favor segmental growth in the future.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2966

U.S. market contributed to largest revenue of USD 2,331.8 million in North America in 2017. High disposable income and various reimbursement policies will enable patients to opt percutaneous coronary intervention procedures. Growing influence for minimally invasive medical devices will aid in growth of coronary stents business. Moreover, various reimbursement and insurance policies by Center for Medicare and Medicaid (CMS) will foster regional growth in foreseeable years.

Coronary Stents Market, by Product
o Drug eluting stents
o Bare metal stents
o Bioresorbable vascular scaffold

Coronary Stents Market, by End-User
o Hospitals
o Cardiac centers
o Ambulatory surgical centers

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.